. Glucagon-like peptide-2 increases sucrase-isomaltase but not caudal-related homeobox protein-2 gene expression. Am. J. Physiol. Gastrointest. Liver Physiol. 278: G425-G428, 2000.-To determine the effect of glucagon-like peptide-2 (GLP-2) on sucraseisomaltase and caudal-related homeobox protein-2 (Cdx-2) gene expression, male Wistar rats were divided into total parenteral nutrition (TPN)-fed and GLP-2-treated, TPN-fed groups. TPN was given via a jugular line, inserted under anesthesia, for 7 days. The treatment group received 40 µg/day of GLP-2 intravenously with the TPN diet. The small intestine and colon were weighed and measured. Tissue was obtained from the jejunum, terminal ileum, and midcolon. RNA analysis, morphometry, and microdissection were performed. The weight of the small intestine of GLP-2-treated rats was greater than that of TPN-fed rats (P Ͻ 0.001). GLP-2 increased the mean metaphase arrests/crypt in both the jejunum and ileum (P Ͻ 0.001). Ileal expression of sucraseisomaltase was increased by 1.6-fold (P Ͻ 0.05). Jejunal expression was increased by a similar amount, although not significantly (P ϭ 0.08). There was no change in Cdx-2 gene expression. Thus GLP-2 can maintain small intestinal morphology and function, but effects on gene expression are not mediated by gross changes in the level of the mRNA for the homeobox protein Cdx-2. total parenteral nutrition; cellular proliferation; jejunum; ileum.
TOTAL PARENTERAL NUTRITION (TPN) can be a life-saving therapy in patients with short bowel syndrome, enterocutaneous fistulae, postoperative care, severe malnutrition, and acute pancreatitis (1) . However, it is associated with several serious complications including infection (9) and immunosuppression (16) , the origins of which may be linked to the ensuing atrophy (36) .
Glucagon-like peptide-2 (GLP-2) is a trophic factor that has been shown to reverse intestinal atrophy in TPN-fed rats (7, 14) . The effects have been studied in a number of other animal models and have been found to have important effects on cell renewal (11) , growth (10) , and intestinal function (7) . One paper to date has investigated the effect of GLP-2 on gene expression in mice (6) . However, the effect of GLP-2 on gene expression in TPN-fed rats has not been determined.
We investigated the effect of GLP-2 on expression of a representative gene in target tissue, sucrase-isomaltase. Changes in sucrase-isomaltase gene expression are a regulatory step in enzyme activity (33, 38) . This has been shown to decrease in TPN feeding in rats (13, 23) and humans (15, 29) . However, it is not known how the sucrase-isomaltase gene is regulated in vivo, but in vitro data suggest a role for caudal-related homeobox protein-2 (Cdx-2; Refs. 26, 31) ; this may also be important in the control of cellular proliferation and differentiation (32) . We therefore investigated the effect of GLP-2 on sucrase-isomaltase and Cdx-2 gene expression in the TPN-fed rat.
METHODS
Two groups of male Wistar rats (mean wt 250 g) were used, with four rats treated with 40 µg/day GLP-2 and TPN and six rats with TPN alone. A Silastic cannula was inserted into the right external jugular vein (22) under a combination anesthetic consisting of 0.10 ml of Hypnorm (0.315 mg/ml fentanyl citrate and 10 mg/ml fluanisone; Janssen Animal Health) intramuscularly and 0.1 mg of diazepam intraperitoneally (Phoenix Pharmaceuticals). The line was then tunneled subcutaneously to exit from the back of the neck. This was then passed through an Instech fluid swivel apparatus (Linton Instrumentation) and attached to the intravenous nutrition system. The rats were housed individually in wire-bottomed cages with free access to water. The refrigerated TPN diet was infused into the rats by a multi-channel peristaltic pump, at a rate of 60 ml · rat Ϫ1 · day Ϫ1 , giving 1.8 g nitrogen, 6 .0 g lipid, 8.5 g glucose, and 1,047 kJ/kg per day.
On the sixth postoperative day the rats were killed at 15-min intervals. This occurred 2 h after an intraperitoneal injection of 1 mg/kg vincristine sulfate (David Bull Laboratories). Terminal anesthesia was induced by pentobarbital sodium injection. The weight of the whole animal, small intestine, and colon was measured, as was the length. Tissue was obtained from 10 cm distal to the ligament of Treitz, 10 cm proximal to the ileocecal valve, and halfway along the colon. This was preserved and stored appropriately for morphometry, RNA analysis, and microdissection. All procedures were approved by the Imperial Cancer Research Fund Animal Ethics Committee.
For histological analysis of the mucosa, formalin-fixed tissue was embedded in wax and 4-µm transverse sections were cut and mounted. These were stained with hematoxylin and eosin, and the villous height and crypt depth were determined using a graticule.
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Total RNA was prepared from snap-frozen mucosal scrapes of the jejunum and terminal ileum as previously described (2) . Aliquots of ϳ25 µg were electrophoresed on agarose gels and blotted on to Hybond N membranes (Amersham Life Science). Each blot also included a sample of RNA from a single control RNA preparation, which was used to standardize between blots. Blots were probed with 32 P-labeled probes for sucrase-isomaltase, Cdx-2, and 18S ribosomal RNA. Hybridization signals were quantified by phosphor imaging (Molecular Dynamics) and adjusted for 18S ribosomal RNA content and the control sample. The rat sucrase-isomaltase probe was cloned from intestinal cDNA and represented bases 18-209 of Genbank entry L25926. The rat Cdx-2 probe and the 18S ribosomal RNA oligonucleotide were as previously described (2) .
For the microdissection technique, tissue was fixed in Carnoy's fluid for 1 h and then stored in 70% ethanol until processed. The specimens were then rehydrated by placing in 50% and then 25% ethanol. After hydrolysis in 1 M hydrochloric acid for 10 min at 60°C, tissue was placed in Schiff's reagent for at least 45 min. The tissue was then separated by microdissection and the arrested metaphases counted in 10 crypts.
Statistics. All results are presented as means Ϯ SE. Data were analyzed using the two-sided unpaired t-test.
RESULTS
The weight of the small intestine of the GLP-2-treated group of rats was doubled compared with that of control TPN-fed rats (P Ͻ 0.001, Table 1 ). Small intestinal length, height of the villi, and depth of the crypts were all significantly increased in the GLP-2-treated group. GLP-2 had no effect on the colon as measured by weight, length, and crypt depth.
GLP-2 increased the number of arrested metaphases per crypt in the jejunum and ileum by 2.6-and 2.3-fold, respectively (P Ͻ 0.001, Table 1 ). In the colon, this was increased 1.5-fold (P Ͻ 0.05).
A representative Northern blot for sucrase-isomaltase is shown in Fig. 1a . Lanes 1 and 2 represent RNA from a GLP-2-treated, TPN-fed rat and lanes 3 and 4 are from a rat fed by TPN alone. Jejunal and ileal RNA are shown in lanes 1 and 3 and 2 and 4, respectively. The signals are higher in the GLP-2 group compared with the TPN group. Figure 1b is the same blot probed for 18S ribosomal RNA, demonstrating that the RNA was equally loaded in each of the lanes.
Representative Northern blots probed for Cdx-2 and 18S ribosomal RNA are shown in Fig. 1, c and d , respectively. The intensities of the Cdx-2 signals were similar in the GLP-2-treated, TPN-fed, and control rats. The RNA loading was comparable between lanes (Fig. 1d) .
The effect of GLP-2 on sucrase-isomaltase gene expression in the jejunum and ileum measured using the PhosphorImager is shown in Table 2 . The sucraseisomaltase transcript levels are expressed as a ratio to 18S ribosomal RNA levels, standardizing for the amount of RNA loading in each lane. In the jejunum, GLP-2 increased mean levels of sucrase-isomaltase 1.7-fold, although this increase failed to achieve significance (P ϭ 0.08). In the ileum there was a similar increase Values are means Ϯ SE; n, no. of rats. TPN, total parental nutrition; GLP-2, glucagon-like peptide 2; ns, not significant. * n ϭ 5 rats. (1.6-fold), and this increase was significant (P Ͻ 0.05). When the data for the jejunum and ileum were normalized and analyzed together, the overall increase in the level of sucrase-isomaltase mRNA caused by GLP-2 treatment was also found to be significant (P Ͻ 0.05).
DISCUSSION
GLP-2 is derived from posttranslational processing of the preproglucagon gene (24) producing a 33-amino acid peptide (3, 5, 27, 28) . This is specifically produced in the L cells located in the distal regions of the intestine (4). GLP-2 binds to a G protein-coupled receptor, transcripts of which are demonstrated with the largest concentration in the jejunum, although they are also found in the ileum and colon (25) . To date, one study in mice has investigated the effect of GLP-2 on gene expression. Sodium-dependent glucose transporter-1 and glucose transporter-2 transcripts were decreased in the GLP-2-treated mice compared with those treated with vehicle alone. However, other markers of intestinal gene expression, such as mRNA transcripts for ornithine decarboxylase, were not altered (6) .
Our data demonstrate that GLP-2 is able to increase sucrase-isomaltase gene expression in the ileum with a similar although nonsignificant increase in the jejunum. This is likely to lead to an increase in sucraseisomaltase enzyme activity (33, 38) and, consequently, function, because in other animal models GLP-2 has been shown to increase sucrase-isomaltase activity (6, 30) . Furthermore, GLP-2 has also been shown to improve intestinal permeability in response to massive intestinal resection (30) , upregulate the sodiumdependent glucose transporter (8) , as well as increase a number of other functional enzymes (6) . These data indicate that GLP-2 may be of great value as a therapeutic agent for improving function of the damaged small intestine.
A role for Cdx-2 in the regulation of sucraseisomaltase gene expression is supported by the literature. Transfection of Cdx-2 into IEC-6 cells, a poorly differentiated small intestinal cell line, regulates both proliferation and differentiation, increasing expression of sucrase-isomaltase (32) . Sucrase-isomaltase expression has been shown to be increased by Cdx-2 binding as a dimer to its promoter region (26, 31) . Furthermore, Cdx-2 has been shown to interact with the promoter of other genes such as lactase-phlorizin hydrolase (35) , calbindin D9K (17), vitamin D receptor (37) , and proglucagon (18) .
However, we have shown that GLP-2 does not increase sucrase-isomaltase gene expression through gross changes in Cdx-2 gene expression in the TPN-fed rat. The reasons for our new finding are unclear. The most likely explanation is that the main function of Cdx-2 is to direct undifferentiated cells to become differentiated enterocytes, expressing sucrase-isomaltase. Changes in Cdx-2 gene expression may therefore be restricted to cells at the base of the crypt and thus be difficult to detect because of the higher background transcript levels. Therefore, once the cell is committed to expressing sucrase-isomaltase, other transcription factors are likely to be important in regulating levels of expression, hepatocyte nuclear factor-1 (34) or cAMP response element-binding protein (21) both being implicated.
We have demonstrated that GLP-2 causes dramatic changes in cellular proliferation that are independent of gross changes in Cdx-2 gene expression. Data have suggested a relationship between cellular proliferation and differentiation and Cdx-2 (19, 20, 31, 32) . In cancer models, it has been shown that Cdx-2 protein expression diminishes as one progresses along the adenomacarcinoma sequence (12) and oncogenic K-ras activation decreases Cdx-2 expression through distinct signaling pathways (19) . However, these findings may not apply to noncancer models such as ours.
We conclude that GLP-2 can induce dramatic changes in the intestine of TPN-fed rats and appears to be one of the most potent agents for the stimulation of gut growth. Furthermore, sucrase-isomaltase gene expression and cellular proliferation are increased by GLP-2. These effects do not appear to be mediated through Cdx-2 gene expression. The magnitude of this response and its localization to the small intestine strongly suggest that it could have therapeutic potential. 
